Blom J A
Eindhoven University of Technology, The Netherlands.
Int J Clin Monit Comput. 1991;8(1):25-34. doi: 10.1007/BF02916089.
During and after many surgical procedures the patient's arterial blood pressure must be artificially decreased to a lower than normal level. Although there are alternatives, infusion of the drug sodium nitroprusside (SNP) is frequently the preferred technique to achieve this controlled hypotension. The fast action of the drug and the danger of a too low pressure make manual control of the SNP infusion flow rate, even if done by an expert, a difficult and demanding task. This is mainly due to an occasional large unpredictable variability over time of the patient's sensitivity to SNP, and to the fact that a multitude of other factors also influence the arterial pressure. Due to these and several other causes, current automatic controllers cannot handle all cases equally well. A new expert system based SNP controller was designed to perform well for all patients, regardless of their characteristics. It monitors and adjusts its own performance, employing a number of heuristics derived from a careful study of the properties of the arterial pressure signal, the effects of SNP and other clinical provocations on the arterial pressure, and the ways in which expert clinicians manually manage the SNP infusion. Expert systems technology allows the new controller to access and employ this type of expert medical knowledge, resulting in expert-level performance. The controller was tested on 30 patients undergoing cardiac surgery, both before, during and after bypass. It was safe, needed little attention, and performed well in all cases.
在许多外科手术过程中及术后,患者的动脉血压必须人为降低至正常水平以下。尽管有其他方法,但输注硝普钠(SNP)药物通常是实现这种控制性低血压的首选技术。该药物起效迅速,且存在血压过低的风险,这使得即使由专家手动控制SNP的输注流速,也是一项艰巨且要求很高的任务。这主要是因为患者对SNP的敏感性偶尔会随时间出现很大的不可预测的变化,以及众多其他因素也会影响动脉血压。由于这些及其他一些原因,目前的自动控制器并不能同等良好地处理所有情况。一种基于专家系统的新型SNP控制器被设计出来,旨在对所有患者都能表现良好,无论其个体特征如何。它通过运用从对动脉血压信号特性、SNP及其他临床刺激对动脉血压的影响以及专家临床医生手动管理SNP输注方式的仔细研究中得出的一些启发式方法,来监测和调整自身性能。专家系统技术使新型控制器能够获取并运用这类专业医学知识,从而实现专家级的性能表现。该控制器在30例接受心脏手术的患者身上进行了测试,包括体外循环前、期间和之后。它安全可靠,几乎无需特别关注,并且在所有情况下都表现良好。